|
1
|
Cao D, Jiang J, You L, Jia Z, Tsukamoto T,
Cai H, Wang S, Hou Z, Suo YE and Cao X: The protective effects of
18β-glycyrrhetinic acid on Helicobacter pylori-infected gastric
mucosa in Mongolian gerbils. BioMed Res Int. 2016:49437932016.
View Article : Google Scholar
|
|
2
|
Darvishi B, Manoochehri S, Kamalinia G,
Samadi N, Amini M, Mostafavi SH, Maghazei S, Atyabi F and Dinarvand
R: Preparation and antibacterial activity evaluation of
18-β-glycyrrhetinic acid loaded PLGA nanoparticles. Iran J Pharm
Res. 14:373–383. 2015.PubMed/NCBI
|
|
3
|
Hasan SK, Khan R, Ali N, Khan AQ, Rehman
MU, Tahir M, Lateef A, Nafees S, Mehdi SJ, Rashid S, et al: 18-β
Glycyrrhetinic acid alleviates 2-acetylaminofluorene-induced
hepatotoxicity in Wistar rats: Role in hyperproliferation,
inflammation and oxidative stress. Hum Exp Toxicol. 34:628–641.
2015. View Article : Google Scholar
|
|
4
|
Wang CY, Kao TC, Lo WH and Yen GC:
Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate
lipopolysaccharide-induced inflammatory response by suppression of
NF-κB through PI3K p110δ and p110γ inhibitions. J Agric Food Chem.
59:7726–7733. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hardy ME, Hendricks JM, Paulson JM and
Faunce NR: 18β-glycyrrhetinic acid inhibits rotavirus replication
in culture. Virol J. 9:962012. View Article : Google Scholar
|
|
6
|
Yano S, Harada M, Watanabe K, Nakamaru K,
Hatakeyama Y, Shibata S, Takahashi K, Mori T, Hirabayashi K, Takeda
M, et al: Antiulcer activities of glycyrrhetinic acid derivatives
in experimental gastric lesion models. Chem Pharm Bull (Tokyo).
37:2500–2504. 1989. View Article : Google Scholar
|
|
7
|
Wang XF, Zhou QM, Lu YY, Zhang H, Huang S
and Su SB: Glycyrrhetinic acid potently suppresses breast cancer
invasion and metastasis by impairing the p38 MAPK-AP1 signaling
axis. Expert Opin Ther Targets. 19:577–587. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sharma G, Kar S, Palit S and Das PK:
18β-glycyrrhetinic acid induces apoptosis through modulation of
Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells. J Cell
Physiol. 227:1923–1931. 2012. View Article : Google Scholar
|
|
9
|
Haghshenas V, Fakhari S, Mirzaie S,
Rahmani M, Farhadifar F, Pirzadeh S and Jalili A: Glycyrrhetinic
acid inhibits cell growth and induces apoptosis in ovarian cancer
a2780 cells. Adv Pharm Bull. 4(Suppl 1): 437–441. 2014.PubMed/NCBI
|
|
10
|
Pirzadeh S, Fakhari S, Jalili A, Mirzai S,
Ghaderi B and Haghshenas V: Glycyrrhetinic acid induces apoptosis
in leukemic HL60 cells through upregulating of CD95/CD178. Int J
Mol Cell Med. 3:272–278. 2014.
|
|
11
|
Hibasami H, Iwase H, Yoshioka K and
Takahashi H: Glycyrrhetic acid (a metabolic substance and aglycon
of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic
leukemia and stomach cancer cells. Int J Mol Med. 17:215–219.
2006.PubMed/NCBI
|
|
12
|
Yamaguchi H, Noshita T, Yu T, Kidachi Y,
Kamiie K, Umetsu H and Ryoyama K: Novel effects of glycyrrhetinic
acid on the central nervous system tumorigenic progenitor cells:
Induction of actin disruption and tumor cell-selective toxicity.
Eur J Med Chem. 45:2943–2948. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Favoriti P, Carbone G, Greco M, Pirozzi F,
Pirozzi RE and Corcione F: Worldwide burden of colorectal cancer: A
review. Updates Surg. 68:7–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arvelo F, Sojo F and Cotte C: Biology of
colorectal cancer. E Cancer Med Sci. 9:5202015.
|
|
15
|
Lombardi L, Morelli F, Cinieri S, Santini
D, Silvestris N, Fazio N, Orlando L, Tonini G, Colucci G and
Maiello E: Adjuvant colon cancer chemotherapy: Where we are and
where we'll go. Cancer Treat Rev. 36(Suppl 3): S34–S41. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Khan K, Wale A, Brown G and Chau I:
Colorectal cancer with liver metastases: Neoadjuvant chemotherapy,
surgical resection first or palliation alone? World J
Gastroenterol. 20:12391–12406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roohbakhsh A, Iranshahy M and Iranshahi M:
Glycyrrhetinic acid and its derivatives: Anti-cancer and cancer
chemopreventive properties, mechanisms of action and structure -
cytotoxic activity relationship. Curr Med Chem. 23:498–517. 2016.
View Article : Google Scholar
|
|
18
|
Liu J, Wang S, Zhang Y, Fan HT and Lin HS:
Traditional Chinese medicine and cancer: History, present
situation, and development. Thorac Cancer. 6:561–569. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krieg A, Werner TA, Verde PE, Stoecklein
NH and Knoefel WT: Prognostic and clinicopathological significance
of survivin in colorectal cancer: A meta-analysis. PLoS One.
8:e653382013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Groner B and Weiss A: Targeting survivin
in cancer: novel drug development approaches. BioDrugs. 28:27–39.
2014. View Article : Google Scholar :
|
|
21
|
Decker P and Muller S: Modulating poly
(ADP-ribose) polymerase activity: Potential for the prevention and
therapy of pathogenic situations involving DNA damage and oxidative
stress. Curr Pharm Biotechnol. 3:275–283. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Koh DW, Dawson TM and Dawson VL: Mediation
of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res.
52:5–14. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zucker S and Vacirca J: Role of matrix
metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis
Rev. 23:101–117. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yadav DK, Kalani K, Khan F and Srivastava
SK: QSAR and docking based semi-synthesis and in vitro evaluation
of 18 β-glycyrrhetinic acid derivatives against human lung cancer
cell line A-549. Med Chem. 9:1073–1084. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang J, Yang L, Yang J, Kuropatwinski K,
Wang W, Liu XQ, Hauser J and Brattain MG: Transforming growth
factor beta induces apoptosis through repressing the
phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer
cells. Cancer Res. 68:3152–3160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang B, Leng C, Wu C, Zhang Z, Dou L, Luo
X, Zhang B and Chen X: Smad4 sensitizes colorectal cancer to
5-fluorouracil through cell cycle arrest by inhibiting the
PI3K/Akt/CDC2/survivin cascade. Oncol Rep. 35:1807–1815. 2016.
|
|
28
|
Zhang X, Shi H, Tang H, Fang Z, Wang J and
Cui S: miR-218 inhibits the invasion and migration of colon cancer
cells by targeting the PI3K/Akt/mTOR signaling pathway. Int J Mol
Med. 35:1301–1308. 2015.PubMed/NCBI
|
|
29
|
Chen JS, Wang Q, Fu XH, Huang XH, Chen XL,
Cao LQ, Chen LZ, Tan HX, Li W, Bi J, et al: Involvement of
PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in
hepatocellular carcinoma: Association with MMP-9. Hepatol Res.
39:177–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu M, Hu Y, Zhang MF, Luo KJ, Xie XY, Wen
J, Fu JH and Yang H: MMP1 promotes tumor growth and metastasis in
esophageal squamous cell carcinoma. Cancer Lett. 377:97–104. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ito S, Kimura K, Haneda M, Ishida Y,
Sawada M and Isobe K: Induction of matrix metalloproteinases (MMP3,
MMP12 and MMP13) expression in the microglia by amyloid-beta
stimulation via the PI3K/Akt pathway. Exp Gerontol. 42:532–537.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kao TC, Shyu MH and Yen GC: Glycyrrhizic
acid and 18beta-glycyrrhetinic acid inhibit inflammation via
PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation.
J Agric Food Chem. 58:8623–8629. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma XT, Wang S, Ye YJ, Du RY, Cui ZR and
Somsouk M: Constitutive activation of Stat3 signaling pathway in
human colorectal carcinoma. World J Gastroenterol. 10:1569–1573.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang
QC, Zhang YJ, Lu R, Chen YX and Fang JY: Inhibition of JAK1,
2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces
tumor cell invasion in colorectal cancer cells. Neoplasia.
10:287–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang SW and Sun YM: The IL-6/JAK/STAT3
pathway: Potential therapeutic strategies in treating colorectal
cancer (Review). Int J Oncol. 44:1032–1040. 2014.PubMed/NCBI
|
|
36
|
Lassmann S, Schuster I, Walch A, Göbel H,
Jütting U, Makowiec F, Hopt U and Werner M: STAT3 mRNA and protein
expression in colorectal cancer: Effects on STAT3-inducible targets
linked to cell survival and proliferation. J Clin Pathol.
60:173–179. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C
and Lin J: STAT3 is necessary for proliferation and survival in
colon cancer-initiating cells. Cancer Res. 71:7226–7237. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tsareva SA, Moriggl R, Corvinus FM,
Wiederanders B, Schütz A, Kovacic B and Friedrich K: Signal
transducer and activator of transcription 3 activation promotes
invasive growth of colon carcinomas through matrix
metalloproteinase induction. Neoplasia. 9:279–291. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He SQ, Gao M, Fu YF and Zhang YN:
Glycyrrhizic acid inhibits leukemia cell growth and migration via
blocking AKT/mTOR/STAT3 signaling. Int J Clin Exp Pathol.
8:5175–5181. 2015.PubMed/NCBI
|
|
40
|
Urosevic J, Nebreda AR and Gomis RR: MAPK
signaling control of colon cancer metastasis. Cell Cycle.
13:2641–2642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cui WJ, Liu Y, Zhou XL, Wang FZ, Zhang XD
and Ye LH: Myosin light chain kinase is responsible for high
proliferative ability of breast cancer cells via anti-apoptosis
involving p38 pathway. Acta Pharmacol Sin. 31:725–732. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Siddiqa A, Long LM, Li L, Marciniak RA and
Kazhdan I: Expression of HER-2 in MCF-7 breast cancer cells
modulates anti-apoptotic proteins survivin and Bcl-2 via the
extracellular signal-related kinase (ERK) and phosphoinositide-3
kinase (PI3K) signalling pathways. BMC Cancer. 8:1292008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Reuben PM and Cheung HS: Regulation of
matrix metalloproteinase (MMP) gene expression by protein kinases.
Front Biosci. 11:1199–1215. 2006. View
Article : Google Scholar
|
|
44
|
Uhlirova M and Bohmann D: JNK- and
Fos-regulated Mmp1 expression cooperates with Ras to induce
invasive tumors in Drosophila. EMBO J. 25:5294–5304. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Davidson B, Givant-Horwitz V, Lazarovici
P, Risberg B, Nesland JM, Trope CG, Schaefer E and Reich R: Matrix
metalloproteinases (MMP), EMMPRIN (extracellular matrix
metalloproteinase inducer) and mitogen-activated protein kinases
(MAPK): Co-expression in metastatic serous ovarian carcinoma. Clin
Exp Metastasis. 20:621–631. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen F, Deng J, Liu X, Li W and Zheng J:
HCRP-1 regulates cell migration and invasion via EGFR-ERK mediated
up-regulation of MMP-2 with prognostic significance in human renal
cell carcinoma. Sci Rep. 5:134702015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Song KH, Kim SH, Noh KH, Bae HC, Kim JH,
Lee HJ, Song J, Kang TH, Kim DW, Oh SJ, et al: Apoptosis inhibitor
5 increases metastasis via Erk-mediated MMP expression. BMB Rep.
48:330–335. 2015. View Article : Google Scholar :
|
|
48
|
Liu Z, Cai H, Zheng X, Zhang B and Xia C:
The involvement of mutual inhibition of ERK and mTOR in
PLCγ1-mediated MMP-13 expression in human osteoarthritis
chondrocytes. Int J Mol Sci. 16:17857–17869. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cho JS, Kang JH, Um JY, Han IH, Park IH
and Lee HM: Lipopolysaccharide induces pro-inflammatory cytokines
and MMP production via TLR4 in nasal polyp-derived fibroblast and
organ culture. PLoS One. 9:e906832014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hammaker DR, Boyle DL, Inoue T and
Firestein GS: Regulation of the JNK pathway by TGF-beta activated
kinase 1 in rheumatoid arthritis synoviocytes. Arthritis Res Ther.
9:R572007. View
Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fromigué O, Hamidouche Z and Marie PJ:
Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces
osteosarcoma cell invasion. J Biol Chem. 283:30549–30556. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sinfield JK, Das A, O'Regan DJ, Ball SG,
Porter KE and Turner NA: p38 MAPK alpha mediates cytokine-induced
IL-6 and MMP-3 expression in human cardiac fibroblasts. Biochem
Biophys Res Commun. 430:419–424. 2013. View Article : Google Scholar :
|
|
54
|
Wang S, Liu Z, Wang L and Zhang X:
NF-kappaB signaling pathway, inflammation and colorectal cancer.
Cell Mol Immunol. 6:327–334. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wang K, Brems JJ, Gamelli RL and Holterman
AX: Survivin signaling is regulated through nuclear factor-kappa B
pathway during glycochenodeoxycholate-induced hepatocyte apoptosis.
Biochim Biophys Acta. 1803:1368–1375. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar
|
|
57
|
Li W, Wang H, Kuang CY, Zhu JK, Yu Y, Qin
ZX, Liu J and Huang L: An essential role for the
Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the
proliferation of endothelial progenitor cells in vitro. Mol Cell
Biochem. 363:135–145. 2012. View Article : Google Scholar :
|
